Organization
Creative Medical Technology Holdings Inc
2 clinical trials
1 abstract
Clinical trial
Clinical Trial to Evaluate the Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (CREATE-1)Status: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
A Double-blinded, Randomized, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Effectiveness of CELZ-201-DDT Administered by Intramuscular Injection for the Treatment of Chronic Lower Back Pain in Patients With Degenerative Disc DiseaseStatus: Recruiting, Estimated PCD: 2025-05-21
Abstract
ANTI-CCP ANTIBODIES INFLUENCE THE AGE AT ONSET OF RHEUMATOID ARTHRITIS Org: Creative Medical Technology Holdings Inc, Rosario University, Statistics Division, Universidad Nacional de Colombia, Leiden University Medical Center,